DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6DR REDDYS
02 6AVYXA HOLDINGS
03 3EUGIA PHARMA SPECLTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2036-02-15
US Patent Number : 12329767
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212501
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-02-15
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2036-02-15
US Patent Number : 10993952
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212501
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-02-15
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2036-02-15
US Patent Number : 12329767
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212501
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-02-15
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2036-02-15
US Patent Number : 10993952
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212501
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-02-15
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2036-02-15
US Patent Number : 12329767
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212501
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-02-15
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Patent Expiration Date : 2036-02-15
US Patent Number : 10993952
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212501
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-02-15
